Once-per-cycle pegfilgrastim (Neulasta) for the management of chemotherapy-induced neutropenia.
about
Advances in PEGylation of important biotech molecules: delivery aspectsEmergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance.Immunomodulatory Response Triggered by the Alkaloids, 3-Amino-7-Benzylbenzimidazo[3,2-a] Quinolinium Chloride (ABQ-48) and 3-Nitro-7-Benzylbenzimidazo [3,2-a] Quinolinium Chloride (NBQ-48)Efficacy and safety of acupuncture for chemotherapy-induced leucopoenia: protocol for a systematic review.Prevention of pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical community oncology program research base.Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia.Long-active granulocyte colony-stimulating factor for peripheral blood hematopoietic progenitor cell mobilization.Randomized phase 2 study of pegylated SN-38 (EZN-2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer.Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients.Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma.Pegfilgrastim compared with filgrastim for cytokine-alone mobilization of autologous haematopoietic stem and progenitor cells.Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphoma.Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy.
P2860
Q28277255-808BCB5B-5BE4-436A-BC84-5F5445CF75EDQ35604072-AB9FBCAC-DC9A-438A-A6F4-41A519A31088Q35743952-CCE1520D-9595-442E-BE39-71461851E404Q36031915-9F93B7F8-F41F-4999-873C-159E7F93FEA9Q36058475-793676A4-47E8-4CB3-963B-D9BA0F8723BDQ38068457-8788D71C-95E7-48DB-B14D-B0B8B567CD93Q38193590-8A83AE4D-F755-4146-9AE5-64A662458E22Q39084455-B61BAB93-1701-41A1-90EC-11C73AE7B9F0Q40369205-C9CE4EC5-7B50-4DA8-85B9-07091E0C288AQ40489362-DFE66D55-8FE9-41E5-8D55-15BA556C9F2FQ45861930-C749DA0A-718A-4FE3-86A5-2004F2F3E16EQ53588155-9570B59C-4614-48C9-9415-46C5E8E24106Q53591512-934BFF2F-B095-458D-97E5-C1DC1408F275
P2860
Once-per-cycle pegfilgrastim (Neulasta) for the management of chemotherapy-induced neutropenia.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Once-per-cycle pegfilgrastim ( ...... motherapy-induced neutropenia.
@ast
Once-per-cycle pegfilgrastim ( ...... motherapy-induced neutropenia.
@en
type
label
Once-per-cycle pegfilgrastim ( ...... motherapy-induced neutropenia.
@ast
Once-per-cycle pegfilgrastim ( ...... motherapy-induced neutropenia.
@en
prefLabel
Once-per-cycle pegfilgrastim ( ...... motherapy-induced neutropenia.
@ast
Once-per-cycle pegfilgrastim ( ...... motherapy-induced neutropenia.
@en
P1433
P1476
Once-per-cycle pegfilgrastim ( ...... motherapy-induced neutropenia.
@en
P2093
Jeffrey Crawford
P356
10.1016/S0093-7754(03)00314-2
P433
4 Suppl 13
P577
2003-08-01T00:00:00Z